醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
CTNM · Contineum Therapeutics, Inc.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Contineum Therapeutics, Inc.（CTNM）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $1.1M；高管董事有效買入 —、有效賣出 —。最近申報 2026-09-08。
買入 Bought—
賣出 Sold$1.1M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-09-08 | Stengone Carmine N. CEO and President, Director | 賣出 Sell | 2,500 | $16.46 | $41K | SEC |
| 2026-08-03 | Stengone Carmine N. CEO and President, Director | 賣出 Sell | 2,500 | $16.01 | $40K | SEC |
| 2026-07-08 | Lorrain Daniel S. Chief Scientific Officer | 賣出 Sell | 1,040 | $16.00 | $17K | SEC |
| 2026-07-08 | Stengone Carmine N. CEO and President, Director | 賣出 Sell | 2,500 | $16.00 | $40K | SEC |
| 2026-06-30 | Lorrain Daniel S. Chief Scientific Officer | 賣出 Sell | 37,179 | $15.99 | $595K | SEC |
| 2026-06-30 | Stengone Carmine N. CEO and President, Director | 賣出 Sell | 10,000 | $16.01 | $160K | SEC |
| 2026-06-30 | Watkins Tim CMO & Head of Development | 賣出 Sell | 10,833 | $16.02 | $174K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-10-01 | Lorrain Daniel S. Officer | 4,170 | $56K | 10b5-1 |
| 2026-09-08 | Stengone Carmine N. Director, Officer | 2,500 | $42K | 10b5-1 |
| 2026-09-01 | Lorrain Daniel S. Officer | 9,520 | $155K | 10b5-1 |
| 2026-08-03 | Lorrain Daniel S. Officer | 9,520 | $147K | 10b5-1 |
| 2026-08-03 | Stengone Carmine N. Director, Officer | 2,500 | $39K | 10b5-1 |
| 2026-07-08 | Stengone Carmine N. Director, Officer | 2,500 | $36K | 10b5-1 |
| 2026-07-01 | Lorrain Daniel S. Officer | 9,520 | $156K | 10b5-1 |
內部人 Insiders
Stengone Carmine N.、Lorrain Daniel S.、Watkins Tim